GLP-1-Fc fusion protein formulation

Details for Australian Patent Application No. 2008275180 (hide)

Owner Eli Lilly and Company

Inventors Ng, Kingman

Agent Spruson & Ferguson

Pub. Number AU-A-2008275180

PCT Pub. Number WO2009/009562

Priority 60/948,855 10.07.07 US

Filing date 9 July 2008

Wipo publication date 15 January 2009

International Classifications

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 38/26 (2006.01) Medicinal preparations containing peptides - Glucagons

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

Event Publications

4 February 2010 PCT application entered the National Phase

  PCT publication WO2009/009562 Priority application(s): WO2009/009562

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008275181-Materials and methods for delivering compositions to selected tissues

2008275179-Methods and compositions for treating pulmonary hypertension and related diseases and disorders